Handling SCD risk in adult congenital heart disease: Should we InVEST in the WCD?
- PMID: 36064259
- PMCID: PMC9463464
- DOI: 10.1016/j.ipej.2022.08.004
Handling SCD risk in adult congenital heart disease: Should we InVEST in the WCD?
References
-
- Waldmann V., Bouzeman A., Duthoit G., Koutbi L., Bessiere F., Labombarda F., et al. Long-term follow-up of patients with tetralogy of fallot and implantable cardioverter defibrillator: the DAI-T4F nationwide registry. Circulation. 2020 Oct 27;142(17):1612–1622. - PubMed
-
- Spar D.S., Bianco N.R., Knilans T.K., Czosek R.J., Anderson J.B. The US experience of the wearable cardioverter-defibrillator in pediatric patients. Circ Arrhythm Electrophysiol. 2018 Jul;11(7) - PubMed
Publication types
LinkOut - more resources
Full Text Sources